Tesamorelin
2 mg daily subcutaneous injection in lower abdomen. Rotate sites. Evening administration preferred.
Descripción
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) that has gained FDA approval for treating HIV-associated lipodystrophy. This innovative peptide specifically targets visceral adipose tissue (VAT) reduction while offering comprehensive benefits for body composition, metabolic health, and overall well-being. Tesamorelin represents a clinical-grade solution for those seeking targeted fat reduction and metabolic optimization.
Clinical Benefits
- Visceral Fat Reduction: Clinically proven to reduce visceral adipose tissue (VAT), leading to significant decreases in abdominal fat accumulation
- Metabolic Health Improvement: Enhances insulin sensitivity and glucose metabolism, supporting overall metabolic function and diabetes prevention
- Lean Body Mass Enhancement: Promotes the development and maintenance of lean muscle tissue while preserving existing muscle mass
- Quality of Life Enhancement: Users report significant improvements in self-esteem, body image, and overall confidence related to body composition changes
- Cardiovascular Benefits: Reduction in visceral fat correlates with improved cardiovascular health markers and reduced disease risk
- Growth Hormone Optimization: Naturally stimulates growth hormone release without suppressing endogenous production
Professional Dosage Protocol
For optimal results and safety, Tesamorelin should be administered according to established clinical guidelines:
This standardized dosage has been extensively studied in clinical trials and represents the optimal balance between efficacy and safety for most individuals.
Administration Guidelines
- Injection Site: Administer in the lower abdomen, carefully avoiding the navel area and any existing scar tissue
- Site Rotation Protocol: Systematically rotate injection sites to minimize local irritation, tissue hardening, and injection site reactions
- Skin Preparation: Ensure injection sites are completely free of scars, bumps, bruises, or any skin conditions that may impair absorption
- Timing Consistency: Administer at the same time each day, preferably in the evening, to maintain consistent blood levels
- Storage Requirements: Store reconstituted product refrigerated and follow proper peptide storage protocols
- Sterile Technique: Always use proper sterile injection techniques and dispose of needles safely
Clinical Grade: Tesamorelin is an FDA-approved peptide with extensive clinical research supporting its safety and efficacy.
Medical Supervision: Due to its potent effects on growth hormone and metabolism, professional oversight is recommended.
Research Use Only: This product is intended for research purposes only.
Minimum Purchase: 5 units required per order.
Individual response to treatment may vary. Consistent daily administration typically yields optimal results within 3-6 months.
Información adicional
| MG | 10 |
|---|
Valoraciones
No hay valoraciones aún.